The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Nucleic Acid-based Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.
The global Nucleic Acid-based Therapeutics market size is expected to reach US$ 705.5 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Nucleic Acid-based Therapeutics in various end use industries. The expanding demands from the Hospitals and Academic & Research Institutes, are propelling Nucleic Acid-based Therapeutics market. Anti-Sense And Anti-Gene, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Short Inhibitory Sequences segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nucleic Acid-based Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nucleic Acid-based Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nucleic Acid-based Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nucleic Acid-based Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nucleic Acid-based Therapeutics covered in this report include Wave Life Sciences, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN, BioMedica and Transgene, etc.
The global Nucleic Acid-based Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Wave Life Sciences
Imugene
Caperna
Phylogica
Protagonist Therapeutics
Benitec Biopharma
EGEN
BioMedica
Transgene
Copernicus Therapeutics
Global Nucleic Acid-based Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nucleic Acid-based Therapeutics market, Segment by Type:
Anti-Sense And Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Global Nucleic Acid-based Therapeutics market, by Application
Hospitals
Academic & Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nucleic Acid-based Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Gene therapy is a technique for correcting defective genes responsible for disease development. Nucleic acid-based molecules (deoxyribonucleic acid, complementary deoxyribonucleic acid, complete genes, ribonucleic acid, and oligonucleotides) are utilized as research tools within the broad borders of gene therapy and the emerging field of molecular medicine.
The global Nucleic Acid-based Therapeutics market size is expected to reach US$ 705.5 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Nucleic Acid-based Therapeutics in various end use industries. The expanding demands from the Hospitals and Academic & Research Institutes, are propelling Nucleic Acid-based Therapeutics market. Anti-Sense And Anti-Gene, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Short Inhibitory Sequences segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Nucleic Acid-based Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Nucleic Acid-based Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Nucleic Acid-based Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Nucleic Acid-based Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Nucleic Acid-based Therapeutics covered in this report include Wave Life Sciences, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN, BioMedica and Transgene, etc.
The global Nucleic Acid-based Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Wave Life Sciences
Imugene
Caperna
Phylogica
Protagonist Therapeutics
Benitec Biopharma
EGEN
BioMedica
Transgene
Copernicus Therapeutics
Global Nucleic Acid-based Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Nucleic Acid-based Therapeutics market, Segment by Type:
Anti-Sense And Anti-Gene
Short Inhibitory Sequences
Gene Transfer Therapy
Nucleoside Analogs
Ribozymes
Aptamers
Global Nucleic Acid-based Therapeutics market, by Application
Hospitals
Academic & Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Nucleic Acid-based Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Nucleic Acid-based Therapeutics
1.1 Nucleic Acid-based Therapeutics Market Overview
1.1.1 Nucleic Acid-based Therapeutics Product Scope
1.1.2 Nucleic Acid-based Therapeutics Market Status and Outlook
1.2 Global Nucleic Acid-based Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Nucleic Acid-based Therapeutics Market Size by Region (2018-2029)
1.4 Global Nucleic Acid-based Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Nucleic Acid-based Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Nucleic Acid-based Therapeutics Market Size (2018-2029)
1.6.1 North America Nucleic Acid-based Therapeutics Market Size (2018-2029)
1.6.2 Europe Nucleic Acid-based Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Nucleic Acid-based Therapeutics Market Size (2018-2029)
1.6.4 Latin America Nucleic Acid-based Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Nucleic Acid-based Therapeutics Market Size (2018-2029)
2 Nucleic Acid-based Therapeutics Market by Type
2.1 Introduction
2.1.1 Anti-Sense And Anti-Gene
2.1.2 Short Inhibitory Sequences
2.1.3 Gene Transfer Therapy
2.1.4 Nucleoside Analogs
2.1.5 Ribozymes
2.1.6 Aptamers
2.2 Global Nucleic Acid-based Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Nucleic Acid-based Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Nucleic Acid-based Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Nucleic Acid-based Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Nucleic Acid-based Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Nucleic Acid-based Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Nucleic Acid-based Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Nucleic Acid-based Therapeutics Revenue Breakdown by Type (2018-2029)
3 Nucleic Acid-based Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Academic & Research Institutes
3.2 Global Nucleic Acid-based Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Nucleic Acid-based Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Nucleic Acid-based Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Nucleic Acid-based Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Nucleic Acid-based Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Nucleic Acid-based Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Nucleic Acid-based Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Nucleic Acid-based Therapeutics Revenue Breakdown by Application (2018-2029)
4 Nucleic Acid-based Therapeutics Competition Analysis by Players
4.1 Global Nucleic Acid-based Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nucleic Acid-based Therapeutics as of 2022)
4.3 Date of Key Players Enter into Nucleic Acid-based Therapeutics Market
4.4 Global Top Players Nucleic Acid-based Therapeutics Headquarters and Area Served
4.5 Key Players Nucleic Acid-based Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Nucleic Acid-based Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Wave Life Sciences
5.1.1 Wave Life Sciences Profile
5.1.2 Wave Life Sciences Main Business
5.1.3 Wave Life Sciences Nucleic Acid-based Therapeutics Products, Services and Solutions
5.1.4 Wave Life Sciences Nucleic Acid-based Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Wave Life Sciences Recent Developments
5.2 Imugene
5.2.1 Imugene Profile
5.2.2 Imugene Main Business
5.2.3 Imugene Nucleic Acid-based Therapeutics Products, Services and Solutions
5.2.4 Imugene Nucleic Acid-based Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Imugene Recent Developments
5.3 Caperna
5.3.1 Caperna Profile
5.3.2 Caperna Main Business
5.3.3 Caperna Nucleic Acid-based Therapeutics Products, Services and Solutions
5.3.4 Caperna Nucleic Acid-based Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Phylogica Recent Developments
5.4 Phylogica
5.4.1 Phylogica Profile
5.4.2 Phylogica Main Business
5.4.3 Phylogica Nucleic Acid-based Therapeutics Products, Services and Solutions
5.4.4 Phylogica Nucleic Acid-based Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Phylogica Recent Developments
5.5 Protagonist Therapeutics
5.5.1 Protagonist Therapeutics Profile
5.5.2 Protagonist Therapeutics Main Business
5.5.3 Protagonist Therapeutics Nucleic Acid-based Therapeutics Products, Services and Solutions
5.5.4 Protagonist Therapeutics Nucleic Acid-based Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Protagonist Therapeutics Recent Developments
5.6 Benitec Biopharma
5.6.1 Benitec Biopharma Profile
5.6.2 Benitec Biopharma Main Business
5.6.3 Benitec Biopharma Nucleic Acid-based Therapeutics Products, Services and Solutions
5.6.4 Benitec Biopharma Nucleic Acid-based Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Benitec Biopharma Recent Developments
5.7 EGEN
5.7.1 EGEN Profile
5.7.2 EGEN Main Business
5.7.3 EGEN Nucleic Acid-based Therapeutics Products, Services and Solutions
5.7.4 EGEN Nucleic Acid-based Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 EGEN Recent Developments
5.8 BioMedica
5.8.1 BioMedica Profile
5.8.2 BioMedica Main Business
5.8.3 BioMedica Nucleic Acid-based Therapeutics Products, Services and Solutions
5.8.4 BioMedica Nucleic Acid-based Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 BioMedica Recent Developments
5.9 Transgene
5.9.1 Transgene Profile
5.9.2 Transgene Main Business
5.9.3 Transgene Nucleic Acid-based Therapeutics Products, Services and Solutions
5.9.4 Transgene Nucleic Acid-based Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Transgene Recent Developments
5.10 Copernicus Therapeutics
5.10.1 Copernicus Therapeutics Profile
5.10.2 Copernicus Therapeutics Main Business
5.10.3 Copernicus Therapeutics Nucleic Acid-based Therapeutics Products, Services and Solutions
5.10.4 Copernicus Therapeutics Nucleic Acid-based Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 Copernicus Therapeutics Recent Developments
6 North America
6.1 North America Nucleic Acid-based Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nucleic Acid-based Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid-based Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nucleic Acid-based Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid-based Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nucleic Acid-based Therapeutics Market Dynamics
11.1 Nucleic Acid-based Therapeutics Industry Trends
11.2 Nucleic Acid-based Therapeutics Market Drivers
11.3 Nucleic Acid-based Therapeutics Market Challenges
11.4 Nucleic Acid-based Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
